|
Enzo Biochem, Inc. - Comparative Business Analysis Snapshot
Business Description
Enzo Biochem, Inc.. The Group's principal activities are researching, developing, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. It operates through three segments: Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Enzo Life Sciences manufactures, develops and markets functional biology and cellular biochemistry products and tools to research and pharmaceutical customers world-wide. Enzo Therapeutics conducts research and development activities in the areas of gastrointestinal infectious, ophthalmic and metabolic diseases. Enzo Clinical Labs provides diagnostic services to the health care community. On 12-Mar-2009, the Group's subsidiary acquired Assay Designs Inc.
Competitor Analysis
This analysis compares Enzo Biochem, Inc. with three other companies in closely related industry sectors.
The full Comparative Business Report is available to Subscribers or may be purchased individually. The full report generally includes the following sections:
- Sales Analysis: Recent Sales, Sales Growth, Sales per Employee
- Recent Stock Performance
- Company Valuation Ratios: Price/Earnings, Price/Book Value
- Price/Sales and 52 Week Price change
- Dividend Analysis
- Profitability Analysis: Gross Profit Margin, EBITDA Margin
- Earnings Before Extraordinary Items
- Inventory Analysis
- Research and Development Expenses
- Financial Position: Long Term Debt/Equity, Days Accounts Receivable, Days Inventory
- R&D Expenses/Sales
Not the Report you are looking for? Click here for more browsing options.
|
